Browse > Article
http://dx.doi.org/10.14348/molcells.2022.0017

m6A in the Signal Transduction Network  

Jang, Ki-Hong (Department of Microbiology and Molecular Genetics, Chao Family Comprehensive Cancer Center, School of Medicine, University of California Irvine)
Heras, Chloe R. (Department of Microbiology and Molecular Genetics, Chao Family Comprehensive Cancer Center, School of Medicine, University of California Irvine)
Lee, Gina (Department of Microbiology and Molecular Genetics, Chao Family Comprehensive Cancer Center, School of Medicine, University of California Irvine)
Publication Information
Molecules and Cells / v.45, no.7, 2022 , pp. 435-443 More about this Journal
Abstract
In response to environmental changes, signaling pathways rewire gene expression programs through transcription factors. Epigenetic modification of the transcribed RNA can be another layer of gene expression regulation. N6-adenosine methylation (m6A) is one of the most common modifications on mRNA. It is a reversible chemical mark catalyzed by the enzymes that deposit and remove methyl groups. m6A recruits effector proteins that determine the fate of mRNAs through changes in splicing, cellular localization, stability, and translation efficiency. Emerging evidence shows that key signal transduction pathways including TGFβ (transforming growth factor-β), ERK (extracellular signal-regulated kinase), and mTORC1 (mechanistic target of rapamycin complex 1) regulate downstream gene expression through m6A processing. Conversely, m6A can modulate the activity of signal transduction networks via m6A modification of signaling pathway genes or by acting as a ligand for receptors. In this review, we discuss the current understanding of the crosstalk between m6A and signaling pathways and its implication for biological systems.
Keywords
ERK; mTOR; $N^6$-methyladenosine; RNA modification; signaling; $TGF{\beta}$;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Villa, E., Sahu, U., O'Hara, B.P., Ali, E.S., Helmin, K.A., Asara, J.M., Gao, P., Singer, B.D., and Ben-Sahra, I. (2021). mTORC1 stimulates cell growth through SAM synthesis and m6A mRNA-dependent control of protein synthesis. Mol. Cell 81, 2076-2093.e9.
2 Jia, G., Fu, Y., Zhao, X., Dai, Q., Zheng, G., Yang, Y., Yi, C., Lindahl, T., Pan, T., Yang, Y.G., et al. (2011). N6-Methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO. Nat. Chem. Biol. 7, 885-887.   DOI
3 Cho, S., Lee, G., Pickering, B.F., Jang, C., Park, J.H., He, L., Mathur, L., Kim, S.S., Jung, S., Tang, H.W., et al. (2021). mTORC1 promotes cell growth via m6A-dependent mRNA degradation. Mol. Cell 81, 2064-2075.e8.   DOI
4 Wang, X., Feng, J., Xue, Y., Guan, Z., Zhang, D., Liu, Z., Gong, Z., Wang, Q., Huang, J., Tang, C., et al. (2016). Structural basis of N6-adenosine methylation by the METTL3-METTL14 complex. Nature 534, 575-578.   DOI
5 Wang, X., Lu, Z., Gomez, A., Hon, G.C., Yue, Y., Han, D., Fu, Y., Parisien, M., Dai, Q., Jia, G., et al. (2014). N 6-methyladenosine-dependent regulation of messenger RNA stability. Nature 505, 117-120.   DOI
6 Wang, X., Zhao, B.S., Roundtree, I.A., Lu, Z., Han, D., Ma, H., Weng, X., Chen, K., Shi, H., and He, C. (2015). N6-methyladenosine modulates messenger RNA translation efficiency. Cell 161, 1388-1399.   DOI
7 Wee, P. and Wang, Z. (2017). Epidermal growth factor receptor cell proliferation signaling pathways. Cancers (Basel) 9, 52.   DOI
8 Wiener, D. and Schwartz, S. (2021). The epitranscriptome beyond m6A. Nat. Rev. Genet. 22, 119-131.   DOI
9 Xiao, W., Adhikari, S., Dahal, U., Chen, Y.S., Hao, Y.J., Sun, B.F., Sun, H.Y., Li, A., Ping, X.L., Lai, W.Y., et al. (2016). Nuclear m6A reader YTHDC1 regulates mRNA splicing. Mol. Cell 61, 507-519.   DOI
10 Xu, C., Wang, X., Liu, K., Roundtree, I.A., Tempel, W., Li, Y., Lu, Z., He, C., and Min, J. (2014). Structural basis for selective binding of m6A RNA by the YTHDC1 YTH domain. Nat. Chem. Biol. 10, 927-929.   DOI
11 Boriack-Sjodin, P.A., Margarit, S.M., Bar-Sagi, D., and Kuriyan, J. (1998). The structural basis of the activation of Ras by Sos. Nature 394, 337-343.   DOI
12 Davies, H., Bignell, G.R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M.J., Bottomley, W., et al. (2002). Mutations of the BRAF gene in human cancer. Nature 417, 949-954.   DOI
13 Dominissini, D., Moshitch-Moshkovitz, S., Schwartz, S., Salmon-Divon, M., Ungar, L., Osenberg, S., Cesarkas, K., Jacob-Hirsch, J., Amariglio, N., Kupiec, M., et al. (2012). Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq. Nature 485, 201-206.   DOI
14 Lee, Y., Choe, J., Park, O.H., and Kim, Y.K. (2020). Molecular mechanisms driving mRNA degradation by m6A modification. Trends Genet. 36, 177-188.   DOI
15 Wojtas, M.N., Pandey, R.R., Mendel, M., Homolka, D., Sachidanandam, R., and Pillai, R.S. (2017). Regulation of m6A transcripts by the 3'→5' RNA helicase YTHDC2 is essential for a successful meiotic program in the mammalian germline. Mol. Cell 68, 374-387.e12.   DOI
16 Yu, F., Wei, J., Cui, X., Yu, C., Ni, W., Bungert, J., Wu, L., He, C., and Qian, Z. (2021). Post-translational modification of RNA m6A demethylase ALKBH5 regulates ROS-induced DNA damage response. Nucleic Acids Res. 49, 5779-5797.   DOI
17 Yue, H., Nie, X., Yan, Z., and Weining, S. (2019). N6-methyladenosine regulatory machinery in plants: composition, function and evolution. Plant Biotechnol. J. 17, 1194-1208.   DOI
18 Yue, Y., Liu, J., Cui, X., Cao, J., Luo, G., Zhang, Z., Cheng, T., Gao, M., Shu, X., Ma, H., et al. (2018). VIRMA mediates preferential m6A mRNA methylation in 3'UTR and near stop codon and associates with alternative polyadenylation. Cell Discov. 4, 10.   DOI
19 Zaccara, S. and Jaffrey, S.R. (2020). A unified model for the function of YTHDF proteins in regulating m6A-modified mRNA. Cell 181, 1582-1595. e18.   DOI
20 Zhao, X., Yang, Y., Sun, B.F., Shi, Y., Yang, X., Xiao, W., Hao, Y.J., Ping, X.L., Chen, Y.S., Wang, W.J., et al. (2014). FTO-dependent demethylation of N6-methyladenosine regulates mRNA splicing and is required for adipogenesis. Cell Res. 24, 1403-1419.   DOI
21 Zhou, B., Liu, C., Xu, L., Yuan, Y., Zhao, J., Zhao, W., Chen, Y., Qiu, J., Meng, M., Zheng, Y., et al. (2021). N6-methyladenosine reader protein YT521-B homology domain-containing 2 suppresses liver steatosis by regulation of mRNA stability of lipogenic genes. Hepatology 73, 91-103.   DOI
22 Losman, J.A., Koivunen, P., and Kaelin, W.G. (2020). 2-Oxoglutaratedependent dioxygenases in cancer. Nat. Rev. Cancer 20, 710-726.   DOI
23 Li, S., Balmain, A., and Counter, C.M. (2018). A model for RAS mutation patterns in cancers: finding the sweet spot. Nat. Rev. Cancer 18, 767-777.   DOI
24 Lin, X., Chai, G., Wu, Y., Li, J., Chen, F., Liu, J., Luo, G., Tauler, J., Du, J., Lin, S., et al. (2019). RNA m 6 A methylation regulates the epithelial mesenchymal transition of cancer cells and translation of Snail. Nat. Commun. 10, 2065.   DOI
25 Liu, J., Yue, Y., Han, D., Wang, X., Fu, Y., Zhang, L., Jia, G., Yu, M., Lu, Z., Deng, X., et al. (2014). A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation. Nat. Chem. Biol. 10, 93-95.   DOI
26 Ma, X.M. and Blenis, J. (2009). Molecular mechanisms of mTOR-mediated translational control. Nat. Rev. Mol. Cell Biol. 10, 307-318.   DOI
27 Mathsyaraja, H., Freie, B., Cheng, P.F., Babaeva, E., Catchpole, J.T., Janssens, D., Henikoff, S., and Eisenman, R.N. (2019). Max deletion destabilizes MYC protein and abrogates Eµ-Myc lymphomagenesis. Genes Dev. 33, 1252-1264.   DOI
28 Mauer, J., Luo, X., Blanjoie, A., Jiao, X., Grozhik, A.V., Patil, D.P., Linder, B., Pickering, B.F., Vasseur, J.J., Chen, Q., et al. (2017). Reversible methylation of m6 Am in the 5' cap controls mRNA stability. Nature 541, 371-375.   DOI
29 Meyer, K.D., Patil, D.P., Zhou, J., Zinoviev, A., Skabkin, M.A., Elemento, O., Pestova, T.V., Qian, S.B., and Jaffrey, S.R. (2015). 5' UTR m6A promotes cap-independent translation. Cell 163, 999-1010.   DOI
30 Meyer, K.D., Saletore, Y., Zumbo, P., Elemento, O., Mason, C.E., and Jaffrey, S.R. (2012). Comprehensive analysis of mRNA methylation reveals enrichment in 3' UTRs and near stop codons. Cell 149, 1635-1646.   DOI
31 Vu, L.P., Pickering, B.F., Cheng, Y., Zaccara, S., Nguyen, D., Minuesa, G., Chou, T., Chow, A., Saletore, Y., Mackay, M., et al. (2017). The N 6-methyladenosine (m 6 A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells. Nat. Med. 23, 1369-1376.   DOI
32 Zaccara, S., Ries, R.J., and Jaffrey, S.R. (2019). Reading, writing and erasing mRNA methylation. Nat. Rev. Mol. Cell Biol. 20, 608-624.   DOI
33 Zhang, X., Wei, L.H., Wang, Y., Xiao, Y., Liu, J., Zhang, W., Yan, N., Amu, G., Tang, X., Zhang, L., et al. (2019). Structural insights into FTO's catalytic mechanism for the demethylation of multiple RNA substrates. Proc. Natl. Acad. Sci. U. S. A. 116, 2919-2924.   DOI
34 Zhang, Y., Alexander, P.B., and Wang, X.F. (2017). TGF-β family signaling in the control of cell proliferation and survival. Cold Spring Harb. Perspect. Biol. 9, a022145.   DOI
35 Yang, Y., Fan, X., Mao, M., Song, X., Wu, P., Zhang, Y., Jin, Y., Yang, Y., Chen, L.L., Wang, Y., et al. (2017). Extensive translation of circular RNAs driven by N 6 -methyladenosine. Cell Res. 27, 626-641.   DOI
36 Ruzicka, K., Zhang, M., Campilho, A., Bodi, Z., Kashif, M., Saleh, M., Eeckhout, D., El-Showk, S., Li, H., Zhong, S., et al. (2017). Identification of factors required for m6A mRNA methylation in Arabidopsis reveals a role for the conserved E3 ubiquitin ligase HAKAI. New Phytol. 215, 157-172.   DOI
37 Shimobayashi, M. and Hall, M.N. (2014). Making new contacts: the mTOR network in metabolism and signalling crosstalk. Nat. Rev. Mol. Cell Biol. 15, 155-162.   DOI
38 Nosella, M.L. and Forman-Kay, J.D. (2021). Phosphorylation-dependent regulation of messenger RNA transcription, processing and translation within biomolecular condensates. Curr. Opin. Cell Biol. 69, 30-40.   DOI
39 Fang, R., Chen, X., Zhang, S., Shi, H., Ye, Y., Shi, H., Zou, Z., Li, P., Guo, Q., Ma, L., et al. (2021). EGFR/SRC/ERK-stabilized YTHDF2 promotes cholesterol dysregulation and invasive growth of glioblastoma. Nat. Commun. 12, 177.   DOI
40 Fujiwara, Y., Wada, K., and Kabuta, T. (2017). Lysosomal degradation of intracellular nucleic acids-multiple autophagic pathways. J. Biochem. 161, 145-154.
41 Ogawa, A., Nagiri, C., Shihoya, W., Inoue, A., Kawakami, K., Hiratsuka, S., Aoki, J., Ito, Y., Suzuki, T., Suzuki, T., et al. (2021). N6-methyladenosine (m6A) is an endogenous A3 adenosine receptor ligand. Mol. Cell 81, 659-674.e7.
42 Patil, D.P., Chen, C.K., Pickering, B.F., Chow, A., Jackson, C., Guttman, M., and Jaffrey, S.R. (2016). M6 A RNA methylation promotes XIST-mediated transcriptional repression. Nature 537, 369-373.   DOI
43 Patil, D.P., Pickering, B.F., and Jaffrey, S.R. (2018). Reading m6A in the transcriptome: m6A-binding proteins. Trends Cell Biol. 28, 113-127.   DOI
44 Chen, W., Zhang, L., Zheng, G., Fu, Y., Ji, Q., Liu, F., Chen, H., and He, C. (2014). Crystal structure of the RNA demethylase ALKBH5 from zebrafish. FEBS Lett. 588, 892-898.   DOI
45 Tanabe, A., Tanikawa, K., Tsunetomi, M., Takai, K., Ikeda, H., Konno, J., Torigoe, T., Maeda, H., Kutomi, G., Okita, K., et al. (2016). RNA helicase YTHDC2 promotes cancer metastasis via the enhancement of the efficiency by which HIF-1α mRNA is translated. Cancer Lett. 376, 34-42.   DOI
46 Wang, Y., Zhang, L., Ren, H., Ma, L., Guo, J., Mao, D., Lu, Z., Lu, L., and Yan, D. (2021). Role of Hakai in m6A modification pathway in Drosophila. Nat. Commun. 12, 2159.   DOI
47 Borea, P.A., Varani, K., Vincenzi, F., Baraldi, P.G., Tabrizi, M.A., Merighi, S., and Gessi, S. (2015). The A 3 adenosine receptor: history and perspectives. Pharmacol. Rev. 67, 74-102.   DOI
48 Derynck, R. and Zhang, Y.E. (2003). Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425, 577-584.   DOI
49 Li, A., Chen, Y.S., Ping, X.L., Yang, X., Xiao, W., Yang, Y., Sun, H.Y., Zhu, Q., Baidya, P., Wang, X., et al. (2017). Cytoplasmic m 6 A reader YTHDF3 promotes mRNA translation. Cell Res. 27, 444-447.   DOI
50 Liu, J., Eckert, M.A., Harada, B.T., Liu, S.M., Lu, Z., Yu, K., Tienda, S.M., Chryplewicz, A., Zhu, A.C., Yang, Y., et al. (2018). m 6 A mRNA methylation regulates AKT activity to promote the proliferation and tumorigenicity of endometrial cancer. Nat. Cell Biol. 20, 1074-1083.   DOI
51 Saxton, R.A. and Sabatini, D.M. (2017). mTOR signaling in growth, metabolism, and disease. Cell 168, 960-976.   DOI
52 Shi, H., Wang, X., Lu, Z., Zhao, B.S., Ma, H., Hsu, P.J., Liu, C., and He, C. (2017). YTHDF3 facilitates translation and decay of N 6-methyladenosine-modified RNA. Cell Res. 27, 315-328.   DOI
53 Kasowitz, S.D., Ma, J., Anderson, S.J., Leu, N.A., Xu, Y., Gregory, B.D., Schultz, R.M., and Wang, P.J. (2018). Nuclear m6A reader YTHDC1 regulates alternative polyadenylation and splicing during mouse oocyte development. PLoS Genet. 14, e1007412.   DOI
54 Kim, J. and Lee, G. (2021). Metabolic control of m6a rna modification. Metabolites 11, 80.   DOI
55 Knuckles, P., Lence, T., Haussmann, I.U., Jacob, D., Kreim, N., Carl, S.H., Masiello, I., Hares, T., Villasenor, R., Hess, D., et al. (2018). Zc3h13/Flacc is required for adenosine methylation by bridging the mRNA-binding factor RbM15/spenito to the m6 a machinery component Wtap/Fl(2)d. Genes Dev. 32, 415-429.   DOI
56 Bertero, A., Brown, S., Madrigal, P., Osnato, A., Ortmann, D., Yiangou, L., Kadiwala, J., Hubner, N.C., De Los Mozos, I.R., Sadee, C., et al. (2018). The SMAD2/3 interactome reveals that TGFβ controls m 6 A mRNA methylation in pluripotency. Nature 555, 256-259.   DOI
57 Mendoza, M.C., Er, E.E., and Blenis, J. (2011). The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation. Trends Biochem. Sci. 36, 320-328.   DOI
58 Scholler, E., Weichmann, F., Treiber, T., Ringle, S., Treiber, N., Flatley, A., Feederle, R., Bruckmann, A., and Meister, G. (2018). Interactions, localization, and phosphorylation of the m 6 A generating METTL3 - METTL14 - WTAP complex. RNA 24, 499-512.   DOI
59 Schreiber-Agus, N., Chin, L., Chen, K., Torres, R., Rao, G., Guida, P., Skoultchi, A.I., and DePinho, R.A. (1995). An amino-terminal domain of Mxi1 mediates anti-myc oncogenic activity and interacts with a homolog of the yeast transcriptional repressor SIN3. Cell 80, 777-786.   DOI
60 Sledz, P. and Jinek, M. (2016). Structural insights into the molecular mechanism of the m6A writer complex. Elife 5, e18434.   DOI
61 Song, H., Feng, X., Zhang, H., Luo, Y., Huang, J., Lin, M., Jin, J., Ding, X., Wu, S., Huang, H., et al. (2019). METTL3 and ALKBH5 oppositely regulate m6A modification of TFEB mRNA, which dictates the fate of hypoxia/reoxygenation-treated cardiomyocytes. Autophagy 15, 1419-1437.   DOI
62 Sun, H.L., Zhu, A.C., Gao, Y., Terajima, H., Fei, Q., Liu, S., Zhang, L., Zhang, Z., Harada, B.T., He, Y.Y., et al. (2020). Stabilization of ERK-phosphorylated METTL3 by USP5 increases m6A methylation. Mol. Cell 80, 633-647.e7.
63 Tang, H.W., Weng, J.H., Lee, W.X., Hu, Y., Gu, L., Cho, S., Lee, G., Binari, R., Li, C., Cheng, M.E., et al. (2021). mTORC1-chaperonin CCT signaling regulates m6A RNA methylation to suppress autophagy. Proc. Natl. Acad. Sci. U. S. A. 118, e2021945118.   DOI
64 Thapar, R. (2015). Structural basis for regulation of RNA-binding proteins by phosphorylation. ACS Chem. Biol. 10, 652-666.   DOI
65 Bujnicki, J.M., Feder, M., Radlinska, M., and Blumenthal, R.M. (2002). Structure prediction and phylogenetic analysis of a functionally diverse family of proteins homologous to the MT-A70 subunit of the human mRNA:m6A methyltransferase. J. Mol. Evol. 55, 431-444.   DOI
66 Lavoie, H. and Therrien, M. (2015). Regulation of RAF protein kinases in ERK signalling. Nat. Rev. Mol. Cell Biol. 16, 281-298.   DOI
67 Lee, G., Zheng, Y., Cho, S., Jang, C., England, C., Dempsey, J.M., Yu, Y., Liu, X., He, L., Cavaliere, P.M., et al. (2017). Post-transcriptional regulation of de novo lipogenesis by mTORC1-S6K1-SRPK2 signaling. Cell 171, 1545-1558. e18.   DOI
68 Geula, S., Moshitch-Moshkovitz, S., Dominissini, D., Mansour, A.A.F., Kol, N., Salmon-Divon, M., Hershkovitz, V., Peer, E., Mor, N., Manor, Y.S., et al. (2015). m6A mRNA methylation facilitates resolution of naive pluripotency toward differentiation. Science 347, 1002-1006.   DOI
69 Guengerich, F.P. (2015). Introduction: Metals in biology: α-Ketoglutarate/iron-dependent dioxygenases. J. Biol. Chem. 290, 20700-20701.   DOI
70 Tuck, M.T. (1992). The formation of internal 6-methyladenine residues in eucaryotic messenger RNA. Int. J. Biochem. 24, 379-386.   DOI
71 Mao, Y., Dong, L., Liu, X.M., Guo, J., Ma, H., Shen, B., and Qian, S.B. (2019). m6A in mRNA coding regions promotes translation via the RNA helicase-containing YTHDC2. Nat. Commun. 10, 5332.   DOI
72 Han, D., Longhini, A.P., Zhang, X., Hoang, V., Wilson, M.Z., and Kosik, K.S. (2022). Dynamic assembly of the mRNA m6A methyltransferase complex is regulated by METTL3 phase separation. PLoS Biol. 20, e3001535.   DOI
73 Hata, A. and Chen, Y.G. (2016). TGF-β signaling from receptors to smads. Cold Spring Harb. Perspect. Biol. 8, a022061.   DOI
74 He, P.C. and He, C. (2021). m 6 A RNA methylation: from mechanisms to therapeutic potential. EMBO J. 40, e105977.
75 Hirayama, M., Wei, F.Y., Chujo, T., Oki, S., Yakita, M., Kobayashi, D., Araki, N., Takahashi, N., Yoshida, R., Nakayama, H., et al. (2020). FTO demethylates cyclin D1 mRNA and controls cell-cycle progression. Cell Rep. 31, 107464.   DOI
76 Hsu, P.J., Zhu, Y., Ma, H., Guo, Y., Shi, X., Liu, Y., Qi, M., Lu, Z., Shi, H., Wang, J., et al. (2017). Ythdc2 is an N6 -methyladenosine binding protein that regulates mammalian spermatogenesis. Cell Res. 27, 1115-1127.   DOI
77 Huang, H., Weng, H., and Chen, J. (2020). m6A modification in coding and non-coding RNAs: roles and therapeutic implications in cancer. Cancer Cell 37, 270-288.   DOI
78 Huang, H., Weng, H., Zhou, K., Wu, T., Zhao, B.S., Sun, M., Chen, Z., Deng, X., Xiao, G., Auer, F., et al. (2019). Histone H3 trimethylation at lysine 36 guides m6A RNA modification co-transcriptionally. Nature 567, 414-419.   DOI
79 Barbieri, I. and Kouzarides, T. (2020). Role of RNA modifications in cancer. Nat. Rev. Cancer 20, 303-322.   DOI
80 James, D., Levine, A.J., Besser, D., and Hemmati-Brivanlou, A. (2005). TGFβ/activin/nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem cells. Development 132, 1273-1282.   DOI
81 Roundtree, I.A., Luo, G.Z., Zhang, Z., Wang, X., Zhou, T., Cui, Y., Sha, J., Huang, X., Guerrero, L., Xie, P., et al. (2017a). YTHDC1 mediates nuclear export of N6-methyladenosine methylated mRNAs. Elife 6, e31311.   DOI
82 Ries, R.J., Zaccara, S., Klein, P., Olarerin-George, A., Namkoong, S., Pickering, B.F., Patil, D.P., Kwak, H., Lee, J.H., and Jaffrey, S.R. (2019). m6A enhances the phase separation potential of mRNA. Nature 571, 424-428.   DOI
83 Roberts, P.J. and Der, C.J. (2007). Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene 26, 3291-3310.   DOI
84 Roundtree, I.A., Evans, M.E., Pan, T., and He, C. (2017b). Dynamic RNA modifications in gene expression regulation. Cell 169, 1187-1200.   DOI
85 Bokar, J.A., Rath-Shambaugh, M.E., Ludwiczak, R., Narayan, P., and Rottman, F. (1994). Characterization and partial purification of mRNA N6-adenosine methyltransferase from HeLa cell nuclei. Internal mRNA methylation requires a multisubunit complex. J. Biol. Chem. 269, 17697-17704.   DOI
86 Meyer, K.D. and Jaffrey, S.R. (2017). Rethinking m6A readers, writers, and erasers. Annu. Rev. Cell Dev. Biol. 33, 319-342.   DOI
87 Perry, R.P., Kelley, D.E., Friderici, K., and Rottman, F. (1975). The methylated constituents of L cell messenger RNA: evidence for an unusual cluster at the 5' terminus. Cell 4, 387-394.   DOI
88 Batista, P.J., Molinie, B., Wang, J., Qu, K., Zhang, J., Li, L., Bouley, D.M., Lujan, E., Haddad, B., Daneshvar, K., et al. (2014). M6A RNA modification controls cell fate transition in mammalian embryonic stem cells. Cell Stem Cell 15, 707-719.   DOI
89 Bokar, J.A., Shambaugh, M.E., Polayes, D., Matera, A.G., and Rottman, F.M. (1997). Purification and cDNA cloning of the AdoMet-binding subunit of the human mRNA (N6-adenosine)-methyltransferase. RNA 3, 1233-1247.
90 Zhou, J., Wan, J., Gao, X., Zhang, X., Jaffrey, S.R., and Qian, S.B. (2015). Dynamic m6 A mRNA methylation directs translational control of heat shock response. Nature 526, 591-594.   DOI
91 Lavoie, H., Gagnon, J., and Therrien, M. (2020). ERK signalling: a master regulator of cell behaviour, life and fate. Nat. Rev. Mol. Cell Biol. 21, 607-632.   DOI
92 Ping, X.L., Sun, B.F., Wang, L., Xiao, W., Yang, X., Wang, W.J., Adhikari, S., Shi, Y., Lv, Y., Chen, Y.S., et al. (2014). Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase. Cell Res. 24, 177-189.   DOI
93 Zhao, B.S., Wang, X., Beadell, A.V., Lu, Z., Shi, H., Kuuspalu, A., Ho, R.K., and He, C. (2017). M6 A-dependent maternal mRNA clearance facilitates zebrafish maternal-to-zygotic transition. Nature 542, 475-478.   DOI
94 Zheng, G., Dahl, J.A., Niu, Y., Fedorcsak, P., Huang, C.M., Li, C.J., Vagbo, C.B., Shi, Y., Wang, W.L., Song, S.H., et al. (2013). ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility. Mol. Cell 49, 18-29.   DOI
95 Fu, Y., Jia, G., Pang, X., Wang, R.N., Wang, X., Li, C.J., Smemo, S., Dai, Q., Bailey, K.A., Nobrega, M.A., et al. (2013). FTO-mediated formation of N6-hydroxymethyladenosine and N 6-formyladenosine in mammalian RNA. Nat. Commun. 4, 1798.   DOI
96 Huang, H., Weng, H., Sun, W., Qin, X., Shi, H., Wu, H., Zhao, B.S., Mesquita, A., Liu, C., Yuan, C.L., et al. (2018). Recognition of RNA N 6 -methyladenosine by IGF2BP proteins enhances mRNA stability and translation. Nat. Cell Biol. 20, 285-295.   DOI